Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Traws Pharma, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 30 | 29 | −1 |
| Shares | 1.75M | 1.57M | −183.4K (−10.5%) |
| Value | $1.54M | $1.01M | −$527.2K (−34.3%) |
New holders (3)
Institutions that held Traws Pharma, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 31,682 | $20.5K | 0.00% |
| Jane Street Group, LLC | 15,156 | $9.79K | 0.00% |
| Cornerstone Planning Group LLC | 33 | $29 | 0.00% |
Sold out (4)
Institutions that held Traws Pharma, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 33,900 | $30.0K |
| Emfo, LLC | 3,333 | $3.00K |
| Parallel Advisors, LLC | 13 | $0 |
| Evoke Wealth, LLC | 4 | $0 |